NicoLab Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $9.9M
Latest Deal Amount
  • Investors
  • 8

NicoLab General Information

Description

Developer of an AI-powered clinical decision support system designed to offer a complete assessment of relevant imaging biomarkers. The company's system assesses all-important biomarkers on emergency computed tomography and notifies on findings, enabling physicians to aid the timely and accurate triaging of stroke victims.

Contact Information

Website
www.nicolab.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Application Software
Decision/Risk Analysis
Primary Office
  • Paasheuvelweg 25
  • Wing B6
  • 1105 BP Amsterdam
  • Netherlands
+31 020 000 0000

NicoLab Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NicoLab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 21-Apr-2021 $9.9M 000.00 Completed Generating Revenue
6. Accelerator/Incubator 28-May-2020 00000 00.000 Completed Generating Revenue
5. Grant 01-Jul-2018 00000 00.000 Completed Generating Revenue
4. Angel (individual) 01-Jan-2018 00.000 00.000 Completed Generating Revenue
3. Grant 26-Jun-2017 00000 00000 Completed Generating Revenue
2. Debt - General 20-Jul-2016 $155K $111K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view NicoLab’s complete valuation and funding history, request access »

NicoLab Executive Team (10)

Name Title Board Seat Contact Info
Merel Boers Ph.D Co-Founder & Chief Executive Officer
Charlie Bell Chief Financial Officer
Kate Backhouse Chief Operating Officer
Renan Barros Ph.D Chief Technology Officer
Henk Marquering Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 5 of 10 executive team members. Get the full list »

NicoLab Board Members (3)

Name Representing Role Since
Nico Klay Self Board Member 000 0000
Paul Guerra NicoLab Board Member 000 0000
Paul Lappin NicoLab Chairman 000 0000
To view NicoLab’s complete board members history, request access »

NicoLab Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NicoLab Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Canaccord Genuity Wealth Management Corporation Minority 000 0000 000000 0
Ellerston Capital Asset Manager Minority 000 0000 000000 0
Washington H Soul Pattinson Corporation Minority 000 0000 000000 0
Techleap Accelerator/Incubator Minority 000 0000 000000 0
European Union Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »